Biotech | August 17, 2022
Merck and Orna Therapeutics collaborate to advance Orna’s nextgen RNA technology
Collaboration supports multiple discovery efforts, including vaccines
Collaboration supports multiple discovery efforts, including vaccines
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
First disclosure from PILOT study of Breyanzi in second-line large B-cell lymphoma underscores important role of cell therapy earlier in treatment paradigm
Recognition illustrates Takeda’s patient-centricity throughout its manufacturing and supply processes
Erytech is evaluating valuable strategic options to leverage its Erycaps platform and its development and manufacturing capabilities with complementary assets and/or a broader corporate transaction
The facility will support clinical development by securing supply that will address the critical demand in the gene therapy and vaccine markets
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
This is the first CAR T cell therapy application filed for the second-line treatment of R/R LBCL in Japan
This collaboration strengthens Akron’s portfolio of off-the-shelf gene-editing technologies while broadening Vor Bio’s collection of nucleases to engineer gene-modified cell therapies
Expanded capabilities across pharma services network accelerate innovation and enhance productivity for customers
Subscribe To Our Newsletter & Stay Updated
